Arthroplasty, Hip Replacement Clinical Trial
Official title:
Efficacy of Surgical Skin Preparation Solutions in Hip Arthroplasty Surgery
| Verified date | June 2019 |
| Source | Lakehead University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This study will assess the efficacy of two of the most commonly used surgical skin-preparation solutions: Chloraprep (chlorhexidine-alcohol) and Duraprep (iodine-alcohol) at eliminating bacteria from the hip site by evaluating the residual bacteria present following surgical skin-preparation.
| Status | Completed |
| Enrollment | 105 |
| Est. completion date | April 6, 2016 |
| Est. primary completion date | January 7, 2016 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: - Has consented for primary total hip arthroplasty by any of the following orthopaedic surgeons: Drs. Kurt Droll, Dave Puskas or Claude Cullinan - Are capable of providing their own consent - Are able to adequately communicate in English to undergo informed consent - Has provided written, informed consent for the study Exclusion Criteria: - Previous hip arthroplasty - Evidence of an open wound at the incision site - Evidence of an abrasion in the vicinity of the planned incision - Evidence of an active infection at or near the surgical site - Evidence of an active infection elsewhere in the body - Are chronically immunosuppressed e.g. transplant - Is deemed not suitable for the study in the opinion of an investigator |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Lakehead University | Thunder Bay Regional Health Sciences Centre |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Post-preparation skin swab | bacterial culture rates following surgical skin preparation | 4 minutes post-skin preparation | |
| Secondary | Post-operative skin swab | bacterial culture rates following surgery | immediately after closure of the incision, before drape is removed from operative site | |
| Secondary | Post-operative wound complications | wound complications at follow-up | 3 months post-surgery |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02580214 -
Immunonutrition in Total Hip Arthroplasty
|
Phase 2/Phase 3 | |
| Completed |
NCT02839876 -
Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty
|
Phase 4 | |
| Recruiting |
NCT06107296 -
Early Perioperative Quality Of Recovery After Hip and Knee Arthroplasty: a Retrospective Comparative Cohort Study
|
||
| Recruiting |
NCT03806114 -
Dislocation Precautions
|
N/A | |
| Completed |
NCT02342236 -
Cerebral Regional Oxygen Saturation and Markers of Brain Damage During Primary Hip Arthroplasty
|
N/A | |
| Completed |
NCT01514006 -
Postoperative Anemia and Functional Outcomes After Fast-track Primary Hip Arthroplasty
|
N/A | |
| Completed |
NCT02338661 -
Clinical Observation Study With the SBG Stem
|